GMDA News and Press, Gamida Cell Ltd. From 05/09/19

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming healthcare conferences taking place in New York City during May. On Thursday, May 16, 2019, members of Gamida Cell’s management te...

The following slide deck was published by Gamida Cell Ltd. in conjunction with this Read more ...

Gamida Cell (NASDAQ: GMDA ): Q1 Net loss of $15.5M. More news on: Gamida Cell Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

– Announces USAN selection of omidubicel as nonproprietary name for company’s investigational NAM-expanded hematopoietic stem cells (formerly known as NiCord ® ) – – Patient enrollment in Phase 3 study of omidubicel expected to be completed in...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Tuesday, May 7, 2019, at 8:30 a.m. ET to review its first quarter 2019 financial results and provide an update on the co...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that Julian Adams, Ph.D., the company’s chief executive officer, will present an overview of the company at the Solebury Trout Class of 2018 Biotech IPOs Investor Day on Friday, April ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Another nice ramp-up of earnings arrives next week to keep investors busy. All told...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that Julian Adams, Ph.D., the company’s chief executive officer, will present an overview of the company at the 18 th Annual Needham Healthcare Conference on Tuesday, April 9, 2019,...

– Shawn Cline Tomasello and Stephen T. Wills bring extensive experience in building successful commercial-stage life sciences companies – Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the nominations of Shawn Cline...